Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H25NO.C6H3N3O7 |
| Molecular Weight | 524.5225 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O.CCC(=O)C(CCN(C)C)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=JRELAUZHQMUKRI-UHFFFAOYSA-N
InChI=1S/C20H25NO.C6H3N3O7/c1-4-19(22)20(15-16-21(2)3,17-11-7-5-8-12-17)18-13-9-6-10-14-18;10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16/h5-14H,4,15-16H2,1-3H3;1-2,10H
| Molecular Formula | C20H25NO |
| Molecular Weight | 295.4186 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H3N3O7 |
| Molecular Weight | 229.1039 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.rexall.ca/articles/view/1486/Cophylac
Sources: http://www.rexall.ca/articles/view/1486/Cophylac
Normethadone is a derivate of opioid analgetic methadone, used as component of antitussive drops in Canada. Illicit drug.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P33535|||Q64064 Gene ID: 25601.0 Gene Symbol: Oprm1 Target Organism: Rattus norvegicus (Rat) Sources: http://www.ncbi.nlm.nih.gov/pubmed/7602488 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Cophylac Approved UseCough |
Doses
| Dose | Population | Adverse events |
|---|---|---|
100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
Disc. AE: Hyporeflexia, Coma... AEs leading to discontinuation/dose reduction: Hyporeflexia Sources: Coma Fever Disseminated intravascular coagulation Hepatocellular injury Renal failure (grade 1) |
15 drop 2 times / day multiple, oral Recommended Dose: 15 drop, 2 times / day Route: oral Route: multiple Dose: 15 drop, 2 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Disc. AE: Opioid abuse, Opioid type dependence... AEs leading to discontinuation/dose reduction: Opioid abuse Sources: Opioid type dependence Respiratory depression (grade 3-5) Neonatal opioid withdrawal syndrome (grade 4) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Coma | Disc. AE | 100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Disseminated intravascular coagulation | Disc. AE | 100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Fever | Disc. AE | 100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Hepatocellular injury | Disc. AE | 100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Hyporeflexia | Disc. AE | 100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Renal failure | grade 1 Disc. AE |
100 mg single, oral Overdose |
healthy, CHILD Health Status: healthy Age Group: CHILD Sex: M Food Status: UNKNOWN Sources: |
| Opioid abuse | Disc. AE | 15 drop 2 times / day multiple, oral Recommended Dose: 15 drop, 2 times / day Route: oral Route: multiple Dose: 15 drop, 2 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Opioid type dependence | Disc. AE | 15 drop 2 times / day multiple, oral Recommended Dose: 15 drop, 2 times / day Route: oral Route: multiple Dose: 15 drop, 2 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Respiratory depression | grade 3-5 Disc. AE |
15 drop 2 times / day multiple, oral Recommended Dose: 15 drop, 2 times / day Route: oral Route: multiple Dose: 15 drop, 2 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Neonatal opioid withdrawal syndrome | grade 4 Disc. AE |
15 drop 2 times / day multiple, oral Recommended Dose: 15 drop, 2 times / day Route: oral Route: multiple Dose: 15 drop, 2 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.rexall.ca/articles/view/1486/Cophylac
Cophylac (normethadone HCl 10 mg and p-hydroxyephedrine HCl 20 mg): 15 drops twice daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:43:37 GMT 2025
by
admin
on
Mon Mar 31 23:43:37 GMT 2025
|
| Record UNII |
632S02T2CC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60975280
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
343874
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
400426
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
632S02T2CC
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
5988-50-1
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |